NIH-funded research R01 grant

The role of Slc25a1 in brain immune cell activation after traumatic brain injury

Official title: The Role of Slc25a1 in Acute Pro-inflammatory Activation of Microglia/Macrophages Post-Traumatic Brain Injury

Funded at Tulane University of Louisiana · NIH-11426288 · Data updated 2026-11-12

This project looks at how a specific cell “gatekeeper” protein (Slc25a1) affects inflammatory brain cells after a traumatic brain injury, with the aim of finding ways to reduce long-term damage.

More Brain Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTulane University of Louisiana
NIH-funded
Lab location1 site (New Orleans, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$474,321
NIH project number1R01NS150283-01
Project IDNIH-11426288 on NIH RePORTER

Who could benefit from this research

Could help

People who have recently suffered a traumatic brain injury and meet study-specific criteria could be eligible for future trials or related sampling efforts.

Less likely to help

Patients without post-injury inflammation or those not meeting eligibility criteria may not benefit from this approach.

What this research studies

After a traumatic brain injury, inflammatory brain cells called microglia and infiltrating macrophages can worsen damage. The study investigates how Slc25a1 regulates energy and metabolism in these cells and how that influences inflammation. By blocking or reducing Slc25a1 activity in model systems, researchers hope to shift cells from a harmful inflammatory state to a protective one, potentially preserving brain function. The work combines cellular and animal models to explore changes in metabolism, epigenetic marks, and neurodegeneration in the acute phase after injury.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that lessen brain damage and improve recovery after traumatic brain injury.

How similar studies have gone: Previous work shows that targeting metabolic regulators can alter immune cell behavior and reduce inflammation in brain injury models.

Where this research is happening

  • Tulane University of Louisiana
    New Orleans, United States
    Active

Researchers

  • Principal investigator: Liu, Ning — Tulane University of Louisiana
  • Study coordinator: Liu, Ning

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.